Nature press on errors

After issuing linkurl:two post-press corrections;http://www.the-scientist.com/blog/display/24413/ to the release notes for a headline grabbing linkurl:news story about human embryonic stem cells;http://www.the-scientist.com/news/display/24363/ last week, Ruth Francis, __Nature__?s senior press officer said she got a lot of calls and emails from editors and journalists. They issued the second correction Friday night about 9pm Francis? time, just before a three day weekend which was bound to rais

Written byBrendan Maher
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
After issuing linkurl:two post-press corrections;http://www.the-scientist.com/blog/display/24413/ to the release notes for a headline grabbing linkurl:news story about human embryonic stem cells;http://www.the-scientist.com/news/display/24363/ last week, Ruth Francis, __Nature__?s senior press officer said she got a lot of calls and emails from editors and journalists. They issued the second correction Friday night about 9pm Francis? time, just before a three day weekend which was bound to raise hackles. She returned my calls at 4am the following Tuesday. I spoke with Francis later that morning and she explained the series of corrections. As for the first one, she said that she realized looking at the numbers of embryos used and the number of cells extracted from those embryos, that they?d left an error in the press release. This was an internal error, she said. Their first clarification on Wednesday didn?t quite clear up the confusion and in fact introduced another error, which is why they sent the second correction on Friday. As far as the article goes it?s a proof of principle, and embryo survival is largely irrelevant. But this finding?s place in an ethical minefield makes such details rather important linkurl:as reporting elsewhere has shown,;http://ksjtracker.mit.edu/?p=1143 and it might have meant a different kind of coverage in the press.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies